Align Technology Future Growth
Future criteria checks 3/6
Align Technology is forecast to grow earnings and revenue by 17.5% and 7.4% per annum respectively. EPS is expected to grow by 18.1% per annum. Return on equity is forecast to be 18.9% in 3 years.
Key information
17.5%
Earnings growth rate
18.1%
EPS growth rate
Medical Equipment earnings growth | 22.5% |
Revenue growth rate | 7.4% |
Future return on equity | 18.9% |
Analyst coverage | Good |
Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,647 | 665 | 868 | 1,081 | 14 |
12/31/2025 | 4,268 | 559 | 805 | 884 | 16 |
12/31/2024 | 4,006 | 437 | 626 | 576 | 15 |
9/30/2024 | 3,961 | 442 | 373 | 499 | N/A |
6/30/2024 | 3,943 | 447 | 405 | 523 | N/A |
3/31/2024 | 3,917 | 462 | 492 | 615 | N/A |
12/31/2023 | 3,862 | 445 | 608 | 786 | N/A |
9/30/2023 | 3,807 | 363 | 686 | 884 | N/A |
6/30/2023 | 3,737 | 314 | 612 | 863 | N/A |
3/31/2023 | 3,705 | 315 | 469 | 738 | N/A |
12/31/2022 | 3,735 | 362 | 277 | 569 | N/A |
9/30/2022 | 3,864 | 511 | 349 | 697 | N/A |
6/30/2022 | 3,990 | 619 | 389 | 785 | N/A |
3/31/2022 | 4,031 | 706 | 531 | 976 | N/A |
12/31/2021 | 3,953 | 772 | 771 | 1,173 | N/A |
9/30/2021 | 3,756 | 740 | 936 | 1,281 | N/A |
6/30/2021 | 3,474 | 698 | 895 | 1,137 | N/A |
3/31/2021 | 2,816 | 458 | 727 | 880 | N/A |
12/31/2020 | 2,472 | 1,776 | 507 | 662 | N/A |
9/30/2020 | 2,287 | 1,738 | 355 | 499 | N/A |
6/30/2020 | 2,160 | 1,701 | 373 | 522 | N/A |
3/31/2020 | 2,409 | 1,889 | 479 | 640 | N/A |
12/31/2019 | 2,407 | 443 | 598 | 747 | N/A |
9/30/2019 | 2,291 | 419 | 609 | 770 | N/A |
6/30/2019 | 2,189 | 417 | 444 | 632 | N/A |
3/31/2019 | 2,079 | 376 | 394 | 595 | N/A |
12/31/2018 | 1,966 | 400 | 331 | 555 | N/A |
9/30/2018 | 1,854 | 313 | 237 | 476 | N/A |
6/30/2018 | 1,734 | 295 | N/A | 498 | N/A |
3/31/2018 | 1,600 | 258 | N/A | 468 | N/A |
12/31/2017 | 1,473 | 231 | N/A | 439 | N/A |
9/30/2017 | 1,345 | 269 | N/A | 357 | N/A |
6/30/2017 | 1,239 | 238 | N/A | 299 | N/A |
3/31/2017 | 1,151 | 219 | N/A | 265 | N/A |
12/31/2016 | 1,080 | 190 | N/A | 248 | N/A |
9/30/2016 | 1,017 | 191 | N/A | 246 | N/A |
6/30/2016 | 946 | 167 | N/A | 246 | N/A |
3/31/2016 | 886 | 148 | N/A | 233 | N/A |
12/31/2015 | 845 | 144 | N/A | 238 | N/A |
9/30/2015 | 814 | 135 | N/A | 230 | N/A |
6/30/2015 | 796 | 145 | N/A | 238 | N/A |
3/31/2015 | 779 | 150 | N/A | 245 | N/A |
12/31/2014 | 762 | 146 | N/A | 227 | N/A |
9/30/2014 | 740 | 149 | N/A | 222 | N/A |
6/30/2014 | 714 | 145 | N/A | 210 | N/A |
3/31/2014 | 684 | 139 | N/A | 194 | N/A |
12/31/2013 | 660 | 64 | N/A | 186 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0HCK's forecast earnings growth (17.5% per year) is above the savings rate (2.1%).
Earnings vs Market: 0HCK's earnings (17.5% per year) are forecast to grow faster than the UK market (14.8% per year).
High Growth Earnings: 0HCK's earnings are forecast to grow, but not significantly.
Revenue vs Market: 0HCK's revenue (7.4% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: 0HCK's revenue (7.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0HCK's Return on Equity is forecast to be low in 3 years time (18.9%).